A citation-based method for searching scientific literature

Amanda M Dossat, Katherine N Wright, Caroline E Strong, Mohamed Kabbaj. Neuropharmacology 2018
Times Cited: 42







List of co-cited articles
341 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Sex differences in the antidepressant-like effects of ketamine.
Nicole Carrier, Mohamed Kabbaj. Neuropharmacology 2013
168
64


Antidepressant effects of ketamine in depressed patients.
R M Berman, A Cappiello, A Anand, D A Oren, G R Heninger, D S Charney, J H Krystal. Biol Psychiatry 2000
47

mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists.
Nanxin Li, Boyoung Lee, Rong-Jian Liu, Mounira Banasr, Jason M Dwyer, Masaaki Iwata, Xiao-Yuan Li, George Aghajanian, Ronald S Duman. Science 2010
42


NMDAR inhibition-independent antidepressant actions of ketamine metabolites.
Panos Zanos, Ruin Moaddel, Patrick J Morris, Polymnia Georgiou, Jonathan Fischell, Greg I Elmer, Manickavasagom Alkondon, Peixiong Yuan, Heather J Pribut, Nagendra S Singh,[...]. Nature 2016
873
40

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Carlos A Zarate, Jaskaran B Singh, Paul J Carlson, Nancy E Brutsche, Rezvan Ameli, David A Luckenbaugh, Dennis S Charney, Husseini K Manji. Arch Gen Psychiatry 2006
40

NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses.
Anita E Autry, Megumi Adachi, Elena Nosyreva, Elisa S Na, Maarten F Los, Peng-fei Cheng, Ege T Kavalali, Lisa M Monteggia. Nature 2011
33


Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure.
Nanxin Li, Rong-Jian Liu, Jason M Dwyer, Mounira Banasr, Boyoung Lee, Hyeon Son, Xiao-Yuan Li, George Aghajanian, Ronald S Duman. Biol Psychiatry 2011
753
26

Repeated ketamine treatment induces sex-specific behavioral and neurochemical effects in mice.
Connor Thelen, Jonathon Sens, Joseph Mauch, Radhika Pandit, Pothitos M Pitychoutis. Behav Brain Res 2016
45
23

Hedonic sensitivity to low-dose ketamine is modulated by gonadal hormones in a sex-dependent manner.
Samantha K Saland, Kristin J Schoepfer, Mohamed Kabbaj. Sci Rep 2016
25
36

Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors.
Sungho Maeng, Carlos A Zarate, Jing Du, Robert J Schloesser, Joseph McCammon, Guang Chen, Husseini K Manji. Biol Psychiatry 2008
843
19

Locomotor sensitization to intermittent ketamine administration is associated with nucleus accumbens plasticity in male and female rats.
C E Strong, K J Schoepfer, A M Dossat, S K Saland, K N Wright, M Kabbaj. Neuropharmacology 2017
24
29

Ketamine and ketamine metabolites as novel estrogen receptor ligands: Induction of cytochrome P450 and AMPA glutamate receptor gene expression.
Ming-Fen Ho, Cristina Correia, James N Ingle, Rima Kaddurah-Daouk, Liewei Wang, Scott H Kaufmann, Richard M Weinshilboum. Biochem Pharmacol 2018
24
29

Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression.
James W Murrough, Andrew M Perez, Sarah Pillemer, Jessica Stern, Michael K Parides, Marije aan het Rot, Katherine A Collins, Sanjay J Mathew, Dennis S Charney, Dan V Iosifescu. Biol Psychiatry 2013
479
16

Ketamine as a Prophylactic Against Stress-Induced Depressive-like Behavior.
Rebecca A Brachman, Josephine C McGowan, Jennifer N Perusini, Sean C Lim, Thu Ha Pham, Charlene Faye, Alain M Gardier, Indira Mendez-David, Denis J David, René Hen,[...]. Biol Psychiatry 2016
134
14

Effects of a ketamine metabolite on synaptic NMDAR function.
Kanzo Suzuki, Elena Nosyreva, Kevin W Hunt, Ege T Kavalali, Lisa M Monteggia. Nature 2017
110
14

Epidemiology of women and depression.
Ronald C Kessler. J Affect Disord 2003
14

Reinforcing properties of an intermittent, low dose of ketamine in rats: effects of sex and cycle.
Katherine N Wright, Caroline E Strong, Marjorie N Addonizio, Naomi C Brownstein, Mohamed Kabbaj. Psychopharmacology (Berl) 2017
19
31

The use of ketamine as an antidepressant: a systematic review and meta-analysis.
Caoimhe M Coyle, Keith R Laws. Hum Psychopharmacol 2015
160
14

Relationship of ketamine's plasma metabolites with response, diagnosis, and side effects in major depression.
Carlos A Zarate, Nancy Brutsche, Gonzalo Laje, David A Luckenbaugh, Swarajya L Vattem Venkata, Anuradha Ramamoorthy, Ruin Moaddel, Irving W Wainer. Biol Psychiatry 2012
189
14

Sex- and dose-dependent abuse liability of repeated subanesthetic ketamine in rats.
Kristin J Schoepfer, Caroline E Strong, Samantha K Saland, Katherine N Wright, Mohamed Kabbaj. Physiol Behav 2019
18
33


Sex Differences in the Temporal Neuromolecular and Synaptogenic Effects of the Rapid-acting Antidepressant Drug Ketamine in the Mouse Brain.
Connor Thelen, Emily Flaherty, Joseph Saurine, Jonathon Sens, Sara Mohamed, Pothitos M Pitychoutis. Neuroscience 2019
24
25

Ventral CA3 Activation Mediates Prophylactic Ketamine Efficacy Against Stress-Induced Depressive-like Behavior.
Alessia Mastrodonato, Randy Martinez, Ina P Pavlova, Christina T LaGamma, Rebecca A Brachman, Alfred J Robison, Christine A Denny. Biol Psychiatry 2018
51
14

Sustained rescue of prefrontal circuit dysfunction by antidepressant-induced spine formation.
R N Moda-Sava, M H Murdock, P K Parekh, R N Fetcho, B S Huang, T N Huynh, J Witztum, D C Shaver, D L Rosenthal, E J Alway,[...]. Science 2019
251
14

Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms.
Panos Zanos, Ruin Moaddel, Patrick J Morris, Lace M Riggs, Jaclyn N Highland, Polymnia Georgiou, Edna F R Pereira, Edson X Albuquerque, Craig J Thomas, Carlos A Zarate,[...]. Pharmacol Rev 2018
417
14

Ketamine treatment reverses behavioral and physiological alterations induced by chronic mild stress in rats.
Lêda S B Garcia, Clarissa M Comim, Samira S Valvassori, Gislaine Z Réus, Laura Stertz, Flávio Kapczinski, Elaine C Gavioli, João Quevedo. Prog Neuropsychopharmacol Biol Psychiatry 2009
176
11

Sex Differences in Nucleus Accumbens Transcriptome Profiles Associated with Susceptibility versus Resilience to Subchronic Variable Stress.
Georgia E Hodes, Madeline L Pfau, Immanuel Purushothaman, H Francisca Ahn, Sam A Golden, Daniel J Christoffel, Jane Magida, Anna Brancato, Aki Takahashi, Meghan E Flanigan,[...]. J Neurosci 2015
226
11

Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial.
James W Murrough, Dan V Iosifescu, Lee C Chang, Rayan K Al Jurdi, Charles E Green, Andrew M Perez, Syed Iqbal, Sarah Pillemer, Alexandra Foulkes, Asim Shah,[...]. Am J Psychiatry 2013
713
11

Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions.
Vaishnav Krishnan, Ming-Hu Han, Danielle L Graham, Olivier Berton, William Renthal, Scott J Russo, Quincey Laplant, Ami Graham, Michael Lutter, Diane C Lagace,[...]. Cell 2007
11

The Effect of a Single Dose of Intravenous Ketamine on Suicidal Ideation: A Systematic Review and Individual Participant Data Meta-Analysis.
Samuel T Wilkinson, Elizabeth D Ballard, Michael H Bloch, Sanjay J Mathew, James W Murrough, Adriana Feder, Peter Sos, Gang Wang, Carlos A Zarate, Gerard Sanacora. Am J Psychiatry 2018
305
11

R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects.
C Yang, Y Shirayama, J-c Zhang, Q Ren, W Yao, M Ma, C Dong, K Hashimoto. Transl Psychiatry 2015
336
11

A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders.
Gerard Sanacora, Mark A Frye, William McDonald, Sanjay J Mathew, Mason S Turner, Alan F Schatzberg, Paul Summergrad, Charles B Nemeroff. JAMA Psychiatry 2017
272
11

Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants.
Ronald S Duman, George K Aghajanian, Gerard Sanacora, John H Krystal. Nat Med 2016
761
11

The role of eukaryotic elongation factor 2 kinase in rapid antidepressant action of ketamine.
Lisa M Monteggia, Erinn Gideons, Ege T Kavalali. Biol Psychiatry 2013
137
11

Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression.
Marije aan het Rot, Katherine A Collins, James W Murrough, Andrew M Perez, David L Reich, Dennis S Charney, Sanjay J Mathew. Biol Psychiatry 2010
450
11

Mechanisms of ketamine action as an antidepressant.
P Zanos, T D Gould. Mol Psychiatry 2018
376
11

Previous Ketamine Produces an Enduring Blockade of Neurochemical and Behavioral Effects of Uncontrollable Stress.
Jose Amat, Samuel D Dolzani, Scott Tilden, John P Christianson, Kenneth H Kubala, Kristi Bartholomay, Katherine Sperr, Nicholas Ciancio, Linda R Watkins, Steven F Maier. J Neurosci 2016
50
11


Single, Repeated, and Maintenance Ketamine Infusions for Treatment-Resistant Depression: A Randomized Controlled Trial.
Jennifer L Phillips, Sandhaya Norris, Jeanne Talbot, Meagan Birmingham, Taylor Hatchard, Abigail Ortiz, Olabisi Owoeye, Lisa A Batten, Pierre Blier. Am J Psychiatry 2019
152
11


Sex differences in the psychopharmacological treatment of depression.
John J Sramek, Michael F Murphy, Neal R Cutler. Dialogues Clin Neurosci 2016
61
9


Antidepressant Potential of (R)-Ketamine in Rodent Models: Comparison with (S)-Ketamine.
Kenichi Fukumoto, Hidetoh Toki, Michihiko Iijima, Takashi Hashihayata, Jun-Ichi Yamaguchi, Kenji Hashimoto, Shigeyuki Chaki. J Pharmacol Exp Ther 2017
142
9

(R)-Ketamine Shows Greater Potency and Longer Lasting Antidepressant Effects Than Its Metabolite (2R,6R)-Hydroxynorketamine.
Chun Yang, Youge Qu, Masahito Abe, Dai Nozawa, Shigeyuki Chaki, Kenji Hashimoto. Biol Psychiatry 2017
113
9

R (-)-ketamine shows greater potency and longer lasting antidepressant effects than S (+)-ketamine.
Ji-Chun Zhang, Su-Xia Li, Kenji Hashimoto. Pharmacol Biochem Behav 2014
201
9

Altered peripheral immune profiles in treatment-resistant depression: response to ketamine and prediction of treatment outcome.
D D Kiraly, S R Horn, N T Van Dam, S Costi, J Schwartz, S Kim-Schulze, M Patel, G E Hodes, S J Russo, M Merad,[...]. Transl Psychiatry 2017
99
9

Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010.
Harvey A Whiteford, Louisa Degenhardt, Jürgen Rehm, Amanda J Baxter, Alize J Ferrari, Holly E Erskine, Fiona J Charlson, Rosana E Norman, Abraham D Flaxman, Nicole Johns,[...]. Lancet 2013
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.